Patterns of urinary β2-microglobulin excretion by patients treated with aminoglycosides
Authors:
- Jerome J. SchentagJSJerome J. Schentag
- Martin E. PlautMPMartin E. Plaut
- 1 May 1980
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 17 (5) , 654-661
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Why Monitor Serum Levels of Gentamicin?Clinical Pharmacokinetics, 1978
- Gentamicin disposition and tissue accumulation on multiple dosingJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Urine analysis for detection of cadmium-induced renal changes, with special reference to β2-microglobulinEnvironmental Research, 1977
- Enzymes of renal origin in urine as indicators of nephrotoxicity*1Toxicology and Applied Pharmacology, 1977
- Persistence of sisomicin and gentamicin in renal cortex and medulla compared with other organs and serum of ratsKidney International, 1976
- PROLONGED EXCRETION OF GENTAMICIN IN A PATIENT WITH UNIMPAIRED RENAL FUNCTIONThe Lancet, 1975
- Renal Handling of β2-Microglobulin in Experimental Renal DiseaseScandinavian Journal of Clinical and Laboratory Investigation, 1975
- Renal Parenchymal Accumulation of Aminoglycoside Antibiotics in RatsThe Journal of Infectious Diseases, 1974
- Maintenance of Renal Function in Salt Loaded Rats Despite Severe Tubular Necrosis Induced by HgCl2Nephron, 1971
- Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of β2-microglobulin, albumin, and total proteinJournal of Clinical Investigation, 1969